Search alternatives:
market decrease » marked decrease (Expand Search), largest decrease (Expand Search), larger decrease (Expand Search)
teer decrease » greater decrease (Expand Search)
a market » _ market (Expand Search), a marker (Expand Search)
i marked » _ marked (Expand Search), _ market (Expand Search), _ marker (Expand Search)
increase » increased (Expand Search)
market decrease » marked decrease (Expand Search), largest decrease (Expand Search), larger decrease (Expand Search)
teer decrease » greater decrease (Expand Search)
a market » _ market (Expand Search), a marker (Expand Search)
i marked » _ marked (Expand Search), _ market (Expand Search), _ marker (Expand Search)
increase » increased (Expand Search)
-
1
-
2
-
3
Cinacalcet administered early in the inactive phase markedly decrease parathyroid Ki-67 index.
Published 2025Subjects: -
4
Y-27632 collaborated with BA to attenuate the increase in the integrity and decrease in the permeability of epithelial barrier injury induced by LPS in Caco2 monolayers.
Published 2024“…<p>(<b>A)</b> Y-27632 collaborated with BA to attenuate the effect of LPS on TEER in Caco2 cells on days 1–22. …”
-
5
-
6
-
7
-
8
-
9
-
10
Evogliptin attenuates the phenotypic switch of VSMCs during CER treatment by decreasing the osteogenesis-associated genes <i>in-vitro.</i>
Published 2025“…<p>(A) Representative images showed calcium deposition (red). …”
-
11
-
12
-
13
-
14
-
15
Effects of GJE extract treatment decreased accumulation of Col1a1.
Published 2025“…<p>Control (A), NF (B), NF + Low dose GJE (C), and NF+High dose GJE (D) groups using immunohistochemistry (10X magnification). Col1a1-positive areas were significantly increased in the NF group compared to controls and were markedly reduced by both low and high GJE doses. …”
-
16
-
17
-
18
-
19
Real-world mepolizumab treatment in patients with severe asthma decreased exacerbations, oral corticosteroid use, and healthcare resource utilization and costs over 4 years: a retr...
Published 2025“…This study evaluated the real-world impact of mepolizumab treatment in patients with severe asthma over a 4-year follow-up period.</p> <p>This was a retrospective cohort study of patients with asthma initiating mepolizumab (index date: first claim, November 2015–September 2019) using the Merative MarketScan Commercial and Medicare Databases. …”
-
20